Apotex decision a warning bell

Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. Yesterday Apotex announced that it will be ceasing supply of two PBS listed prescription products from its portfolio: paracetamol/codeine tablets 500mg/30mg blister pack 20; and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Queensland pharmacist vaccination now permanent
Next Aussies encouraged to vaccinate and help kids in India